Ultra short-acting intravenous beta-adrenergic blockade add-on therapy acute unstable angina efficacy safety ultra short-acting beta-blocking agent esmolol acute unstable angina esmolol patients persistent conventional medical therapy baseline Doppler echocardiographic examination esmolol rate-pressure product patients maintenance dosage minutes Doppler echocardiographic studies Mean target response mg/min dosage range mg/min Esmolol effective anginal chest pain patients Seven patients underwent percutaneous transluminal coronary angioplasty PTCA coronary bypass surgery remainder medical therapy oral beta-blockade esmolol therapy heart rate blood pressure beats/min mm Hg Cardiac output L/min secondary decrease heart rate stroke volume unchanged Left ventricular ejection fraction esmolol therapy change significant third fraction E/A ratio ratio early-to-late diastolic velocities esmolol therapy improvement left ventricular diastolic function 